,Study_ID,country,nchild,nobs,Country,Short_ID,Short_Description,included,included_anthropometry,included_longitudinal,included_low_income,included_small,included_age,included_ill,included_qc,included_measurement_freq,measurefreq,included_monthly
1,INTERBIO-21,BRAZIL,247,364,BRA,ib21,INTERBIO-21,0,1,1,1,1,0,1,1,NA,NA,NA
2,INTERBIO-21,KENYA,332,454,KEN,ib21,INTERBIO-21,0,1,1,1,1,0,1,1,NA,NA,NA
3,INTERBIO-21,PAKISTAN,262,368,PAK,ib21,INTERBIO-21,0,1,1,1,1,0,1,1,NA,NA,NA
4,INTERBIO-21,SOUTH AFRICA,300,398,ZAF,ib21,INTERBIO-21,0,1,1,1,1,0,1,1,NA,NA,NA
5,INTERBIO-21,THAILAND,532,866,THA,ib21,INTERBIO-21,0,1,1,1,1,0,1,1,NA,NA,NA
6,INTERBIO-21,UNITED KINGDOM,556,983,GBR,ib21,INTERBIO-21,0,1,1,0,1,0,1,1,NA,NA,NA
7,INTERGROWTH-21,CHINA,612,930,CHN,ig21,INTERGROWTH-21,0,1,1,1,1,NA,1,1,NA,NA,NA
8,INTERGROWTH-21,INDIA,625,1546,IND,ig21,INTERGROWTH-21,0,1,1,1,1,NA,1,1,NA,NA,NA
9,INTERGROWTH-21,ITALY,521,1007,ITA,ig21,INTERGROWTH-21,0,1,1,0,1,NA,1,1,NA,NA,NA
10,INTERGROWTH-21,KENYA,611,1267,KEN,ig21,INTERGROWTH-21,0,1,1,1,1,NA,1,1,NA,NA,NA
11,INTERGROWTH-21,KENYA,611,1267,KEN,ig21,INTERGROWTH-21,0,1,1,1,1,NA,1,1,NA,NA,NA
12,INTERGROWTH-21,OMAN,636,1152,OMN,ig21,INTERGROWTH-21,0,1,1,0,1,NA,1,1,NA,NA,NA
13,INTERGROWTH-21,UNITED KINGDOM,619,1079,GBR,ig21,INTERGROWTH-21,0,1,1,0,1,NA,1,1,NA,NA,NA
14,GEMS-1,BANGLADESH,2663,5131,BGD,gems,GEMS-1 Study,0,1,1,1,1,1,0,1,NA,NA,NA
15,GEMS-1,GAMBIA,2072,3764,GMB,gems,GEMS-1 Study,0,1,1,1,1,1,0,1,NA,NA,NA
16,GEMS-1,INDIA,2543,4873,IND,gems,GEMS-1 Study,0,1,1,1,1,1,0,1,NA,NA,NA
17,GEMS-1,KENYA,2374,4547,KEN,gems,GEMS-1 Study,0,1,1,1,1,1,0,1,NA,NA,NA
18,GEMS-1,MALI,2824,5155,MLI,gems,GEMS-1 Study,0,1,1,1,1,1,0,1,NA,NA,NA
19,GEMS-1,MOZAMBIQUE,1649,3027,MOZ,gems,GEMS-1 Study,0,1,1,1,1,1,0,1,NA,NA,NA
20,GEMS-1,PAKISTAN,2327,4152,PAK,gems,GEMS-1 Study,0,1,1,1,1,1,0,1,NA,NA,NA
21,GEMS-1A,BANGLADESH,1668,3226,BGD,gmsa,GEMS-1A Study,0,1,1,1,1,1,0,1,NA,NA,NA
22,GEMS-1A,GAMBIA,1688,3132,GMB,gmsa,GEMS-1A Study,0,1,1,1,1,1,0,1,NA,NA,NA
23,GEMS-1A,INDIA,1557,2951,IND,gmsa,GEMS-1A Study,0,1,1,1,1,1,0,1,NA,NA,NA
24,GEMS-1A,KENYA,646,1246,KEN,gmsa,GEMS-1A Study,0,1,1,1,1,1,0,1,NA,NA,NA
25,GEMS-1A,MALI,1846,3455,MLI,gmsa,GEMS-1A Study,0,1,1,1,1,1,0,1,NA,NA,NA
26,GEMS-1A,MOZAMBIQUE,1079,2044,MOZ,gmsa,GEMS-1A Study,0,1,1,1,1,1,0,1,NA,NA,NA
27,GEMS-1A,PAKISTAN,1582,2935,PAK,gmsa,GEMS-1A Study,0,1,1,1,1,1,0,1,NA,NA,NA
28,MAL-ED,BANGLADESH,265,5572,BGD,mlex,MAL-ED Study,1,1,1,1,1,1,1,1,1,monthly,1
29,MAL-ED,BRAZIL,233,4685,BRA,mlex,MAL-ED Study,1,1,1,1,1,1,1,1,1,monthly,1
30,MAL-ED,INDIA,251,5656,IND,mlex,MAL-ED Study,1,1,1,1,1,1,1,1,1,monthly,1
31,MAL-ED,NEPAL,240,5663,NPL,mlex,MAL-ED Study,1,1,1,1,1,1,1,1,1,monthly,1
32,MAL-ED,PERU,303,5890,PER,mlex,MAL-ED Study,1,1,1,1,1,1,1,1,1,monthly,1
33,MAL-ED,SOUTH AFRICA,314,6060,ZAF,mlex,MAL-ED Study,1,1,1,1,1,1,1,1,1,monthly,1
34,MAL-ED,"TANZANIA, UNITED REPUBLIC OF",262,5686,TZA,mlex,MAL-ED Study,1,1,1,1,1,1,1,1,1,monthly,1
35,CMC-V-BCS-2002,INDIA,373,8744,IND,cmc,CMC Vellore Birth Cohort 2002,1,1,1,1,1,1,1,1,1,monthly,1
36,IRC,INDIA,410,9826,IND,irc,Vellore Crypto Study,1,1,1,1,1,1,1,1,1,monthly,1
37,TDC,INDIA,160,3594,IND,tdc,Transmission Dynamics of Cryptosporidial Infections,0,1,1,1,0,1,1,1,NA,NA,NA
38,EE,PAKISTAN,380,6431,PAK,ee,Study of Biomarkers for Environmental Enteropathy,1,1,1,1,1,1,1,1,1,monthly,1
39,Grip,PAKISTAN,203,1427,PAK,grip,"LRTI, RSV and Influenza Cohort Study",0,1,1,1,1,1,0,1,NA,NA,NA
40,ResPak,PAKISTAN,278,3120,PAK,rspk,Respiratory Pathogens Birth Cohort,1,1,1,1,1,1,1,1,1,monthly,1
41,WASH-Bangladesh,BANGLADESH,4823,8389,BGD,wsb,WASH Benefits Bangladesh Trial,1,1,1,1,1,0,1,1,0,NA,NA
42,WASH-Kenya,KENYA,6743,8968,KEN,wsk,WASH Benefits Kenya Trial,1,1,1,1,1,NA,1,1,0,NA,NA
43,MaliMMAM,MALI,447,3710,MLI,mmam,Deuterium dilution study in Mali,0,1,1,1,1,1,0,1,NA,NA,NA
44,Detroit-Longitudinal,UNITED STATES,480,1276,USA,dtwl,Detroit Longitudinal Cohort,0,1,1,0,1,1,1,1,NA,NA,NA
45,AgaKhanUniv,PAKISTAN,1760,3953,PAK,akup,Aga Khan University Nutrition Intervention Study,1,1,1,1,1,1,1,1,0,NA,NA
46,POPS,NETHERLANDS,1220,3609,NLD,pops,Project On Preterm and SGA Infants 1983,0,1,1,0,1,1,1,1,NA,NA,NA
47,SMOCC,NETHERLANDS,2026,14310,NLD,smcc,Social Medical Survey of Children attending Child health Clinics,0,1,1,0,1,1,1,1,NA,NA,NA
48,UMN-Amplatz,UNITED STATES,56,715,USA,uma,University of Minnesota Amplatz Study,0,1,1,0,0,1,0,1,NA,NA,NA
49,UMN-MINNoWS,UNITED STATES,116,323,USA,umi,University of Minnesota MINNOWS Study,0,1,1,0,0,0,1,1,NA,NA,NA
50,UMN-MOD,UNITED STATES,46,611,USA,umm,University of Minnesota MOD Study,0,1,1,0,0,1,0,1,NA,NA,NA
51,UMN-NORM,UNITED STATES,170,199,USA,umn,University of Minnesota NORM Study,0,1,1,0,0,1,0,1,NA,NA,NA
52,BIGCS Ultrasound,CHINA,3423,9691,CHN,bigu,Born in Guangzhou Cohort Study - Ultrasound Subset,0,1,1,1,1,1,1,1,NA,NA,NA
53,HealthyStart,UNITED STATES,1305,7569,USA,hlts,Healthy Start Study,0,1,1,0,1,0,1,1,NA,NA,NA
54,DIVIDS,INDIA,2099,10972,IND,dvds,DIVIDS-1 with 5 year Follow-up,0,1,1,1,1,1,1,1,NA,NA,NA
55,EU,INDIA,2020,3522,IND,eu,Zn Supp for Diarrheal Pneuomonia,1,1,1,1,1,1,1,1,0,NA,NA
56,LBW,INDIA,2049,9815,IND,zlbw,Zn Supp Trial in LBW,0,1,1,1,1,1,1,1,NA,NA,NA
57,VITAMIN-A,INDIA,3806,11198,IND,vita,EPI Linked Vita A,1,1,1,1,1,1,1,1,0,NA,NA
58,Vitamin-B12,INDIA,805,1360,IND,vb12,Vit B12 Supp Trial,1,1,1,1,1,1,1,1,0,NA,NA
59,ZnMort,INDIA,2288,2289,IND,zmrt,Zn Supp and Infant Mortality,1,1,1,1,1,1,1,1,0,NA,NA
60,SAS-CompFeed,INDIA,1533,9530,IND,cmpf,Optimal Infant Feeding Practices,1,1,1,1,1,1,1,1,1,quarterly,0
61,SAS-FoodSuppl,INDIA,418,2247,IND,fspp,Randomized Food Supplementation Trial Ages 4-12 Months,1,1,1,1,1,1,1,1,1,quarterly,0
62,ZincInf,INDIA,374,1460,IND,zinf,Zn Treatment for Diarrhea,0,1,1,1,1,1,0,1,NA,NA,NA
63,ZincSGA,INDIA,1992,11691,IND,zsga,Zinc supplementation in SGA infants,0,1,1,1,1,1,0,1,NA,NA,NA
64,NIH-Birth,BANGLADESH,629,6216,BGD,nbrt,NIH Birth Cohort Study,1,1,1,1,1,1,1,1,1,quarterly,0
65,PROVIDE,BANGLADESH,700,9090,BGD,prvd,PROVIDE Study,1,1,1,1,1,1,1,1,1,monthly,1
66,NIH-Crypto,BANGLADESH,758,6916,BGD,ncry,NIH Cryptosporidium Cohort Study,1,1,1,1,1,1,1,1,1,quarterly,0
67,TanzaniaChild2,"TANZANIA, UNITED REPUBLIC OF",2396,29594,TZA,tzc2,Tanzania Child 2,1,1,1,1,1,1,1,1,1,monthly,1
68,Keneba,GAMBIA,2923,40377,GMB,knba,MRC Kenaba,1,1,1,1,1,1,1,1,1,monthly,1
69,Bangladesh Diarrhea,BANGLADESH,125,1038,BGD,bngd,Longitudinal Growth Study,0,1,1,1,0,1,1,1,NA,NA,NA
70,Burkina Faso Zn,BURKINA FASO,7167,15155,BFA,bfzn,Zn Trial in Burkina Faso,1,1,1,1,1,1,1,1,0,NA,NA
71,Ecuador Zn,ECUADOR,463,1120,ECU,eczn,Ecuador Zn Trial,0,1,1,1,1,1,1,1,NA,NA,NA
72,Guatemala BSC,GUATEMALA,315,2547,GTM,gbsc,Longitudinal study of BSC in Guatemala,1,1,1,1,1,1,1,1,1,monthly,1
73,Peru Huascar,PERU,153,1839,PER,phua,Infant Growth in Peru,0,1,1,1,0,1,1,1,NA,NA,NA
74,Peru PersistDiarrhea,PERU,312,1445,PER,ppd,Peru Persistent Diarrhea,0,1,1,1,1,1,0,1,NA,NA,NA
75,Peru Zn,PERU,302,1140,PER,pzn,Peru Zn Fortification,0,1,1,1,1,1,0,1,NA,NA,NA
76,iLiNS-Zinc,BURKINA FASO,3266,9987,BFA,lnsz,iLiNS-Zinc Study,1,1,1,1,1,1,1,1,1,quarterly,0
77,GMS-Nepal,NEPAL,602,12796,NPL,gmsn,"Growth Monitoring Study, Nepal",1,1,1,1,1,1,1,1,1,monthly,1
78,CMIN,BANGLADESH,279,5400,BGD,cmin,Child Malnutrition and Infection Network,1,1,1,1,1,1,1,1,1,monthly,1
79,CMIN,BRAZIL,119,889,BRA,cmin,Child Malnutrition and Infection Network,1,1,1,1,1,1,1,1,1,quarterly,0
80,CMIN,GUINEA-BISSAU,1507,9157,GNB,cmin,Child Malnutrition and Infection Network,1,1,1,1,1,1,1,1,1,quarterly,0
81,CMIN,PERU,929,12083,PER,cmin,Child Malnutrition and Infection Network,1,1,1,1,1,1,1,1,1,monthly,1
82,CONTENT,PERU,215,8339,PER,cntt,Eval. of Neglected Enteric Infections,1,1,1,1,1,1,1,1,1,monthly,1
83,PROBIT,BELARUS,16898,124197,BLR,prbt,PROBIT Study,1,1,1,1,1,1,1,1,1,quarterly,0
84,BAMBAM,UNITED STATES,302,495,USA,bmbm,Brain Myelination in Children,0,1,1,0,1,1,1,1,NA,NA,NA
85,ZVITAMBO,ZIMBABWE,14086,64341,ZWE,zvit,ZVITAMBO,1,1,1,1,1,1,1,1,1,quarterly,0
86,GUSTO,SINGAPORE,1158,8582,SGP,gsto,GUSTO,0,1,1,0,1,0,1,1,NA,NA,NA
87,COHORTS,BRAZIL,4852,5710,BRA,cort,COHORTS,1,1,1,1,1,1,1,1,1,NA,NA
88,COHORTS,GUATEMALA,1368,7765,GTM,cort,COHORTS,1,1,1,1,1,1,1,1,1,quarterly,0
89,COHORTS,INDIA,7421,31861,IND,cort,COHORTS,1,1,1,1,1,1,1,1,1,quarterly,0
90,COHORTS,PHILIPPINES,3058,32578,PHL,cort,COHORTS,1,1,1,1,1,1,1,1,1,quarterly,0
91,COHORTS,SOUTH AFRICA,1557,1796,ZAF,cort,COHORTS,1,1,1,1,1,1,1,1,1,NA,NA
92,Fels,UNITED STATES,1029,6597,USA,fels,The Fels Longitudinal Study,0,1,1,0,1,1,1,1,NA,NA,NA
93,LCNI-5,MALAWI,840,4337,MWI,lcn5,Lungwena Child Nutrition Intervention Study 5,1,1,1,1,1,1,1,1,1,quarterly,0
94,iLiNS-DOSE,MALAWI,1931,5129,MWI,ilnd,iLiNS-DOSE,1,1,1,1,1,1,1,1,0,NA,NA
95,iLiNS-DYAD-M,MALAWI,1205,4175,MWI,ildm,iLiNS-DYAD-M,1,1,1,1,1,0,1,1,0,NA,NA
96,Ecuador Egg,ECUADOR,160,308,ECU,eegg,Ecuador Egg Trial,0,1,1,1,0,1,1,1,NA,NA,NA
97,JiVitA-3,BANGLADESH,27324,107725,BGD,jvt3,JiVitA-3 Study,1,1,1,1,1,0,1,1,1,quarterly,0
98,JiVitA-4,BANGLADESH,5443,35936,BGD,jvt4,JiVitA-4 Study,1,1,1,1,1,1,1,1,1,quarterly,0
